<DOC>
	<DOCNO>NCT00982527</DOCNO>
	<brief_summary>The purpose study determine whether fenoldopam infusion cardiopulmonary bypass young child congenital heart disease able reduce indicator acute kidney injury ( biomarkers reduction , diuresis increase ) compare control group .</brief_summary>
	<brief_title>Fenoldopam Pediatric Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Fenoldopam</mesh_term>
	<criteria>Children congenital heart disease , less one year old , undergoing surgery use cardiopulmonary bypass Children one year old , correction ventricular atrial septal defect , need deep hypothermic circulatory arrest , preoperative renal dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>365 Days</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>pediatric cardiac surgery</keyword>
	<keyword>acute renal failure</keyword>
	<keyword>renal biomarkers</keyword>
	<keyword>fenoldopam</keyword>
	<keyword>Focus optimization perfusion pediatric CPB</keyword>
</DOC>